Litcius/Paper detail

Stereotactic Ablative Radiation Therapy for Oligometastatic Ovarian Cancer Lymph Node Disease: The MITO-RT3/RAD Phase II Trial

Gabriella Macchia, Maura Campitelli, Donato Pezzulla, Simona Lucci, Andrei Fodor, Donatella Russo, Vittoria Balcet, Paolo Bonome, Stefano Durante, Lorena Draghini, Francesca Titone, Giuseppe Roberto D’Agostino, Marinella Tamburo, Martina Ferioli, Edy Ippolito, F. Tortoreto, L. Caravatta, Francesca De Felice, Aida Di Stefano, Mara Fanelli, Savino Cilla, Francesco Cosentino, Cláudia Marchetti, Vanda Salutari, Serena Maria Boccia, A.G. Morganti, Maria Antonietta Gambacorta, Anna Fagotti, Sandro Pignata, Giovanni Scambia, Gabriella Ferrandina, Francesco Deodato

2024International Journal of Radiation Oncology*Biology*Physics17 citationsDOI

Topics & Concepts

Ablative caseMedicineRadiation therapyOncologyLymph nodeOvarian cancerInternal medicineCancerRadiologyOvarian cancer diagnosis and treatmentPARP inhibition in cancer therapyEndometrial and Cervical Cancer Treatments
Stereotactic Ablative Radiation Therapy for Oligometastatic Ovarian Cancer Lymph Node Disease: The MITO-RT3/RAD Phase II Trial | Litcius